Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 7Phase 1/2 3Phase EARLY_PHASE1 1

Status

Completed 9Recruiting 4Unknown 3Terminated 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Lung Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 75Carboplatin 61Cyclophosphamide 58Nivolumab 50Paclitaxel 47Gemcitabine 44Cisplatin 43Dexamethasone 41Radiotherapy 35Rituximab 32Capecitabine 31Docetaxel 29Bevacizumab 29fludarabine 27atezolizumab 26Cytarabine 26avelumab 24Trastuzumab 23Oxaliplatin 23Lenalidomide 23Cetuximab 23venetoclax 22Fluorouracil 22Azacitidine 22Temozolomide 21Ipilimumab 21130-nm albumin-bound paclitaxel 21fludarabine phosphate 20Filgrastim 20Bortezomib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × Hydroxychloroquine × Clear all
NCT04214418 2024-12-18

MEKiAUTO

Columbia University

Phase 1/2 Terminated
27 enrolled 12 charts
Gastrointestinal

Gastrointestinal Neoplasms

NCT00765765 2023-08-09

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Rutgers, The State University of New Jersey

Phase 1/2 Terminated
6 enrolled 7 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00728845 2017-05-23

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Rutgers, The State University of New Jersey

Phase 1/2 Terminated
8 enrolled 6 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡